Midtier gold producer and explorer Gold Road Resources has unveiled the findings of a prefeasibility study (PFS) for its 100%-owned ... that is expected to produce 200 000 oz over a four-year ...

The OPFS estimates a net present value of $2.3-billion, compared with the $2.4-billion estimated in the initial PFS. The project is expected to deliver earnings before interest, taxes ...

The CEO discussed the success of Dupixent and the remarkable achievement of over $13 billion in global sales in 2024, highlighting its commercial advantage and setting a milestone for Sanofi.

By Keith Caulfield Following its first full week of activity, Bad Bunny’s Debí Tirar Más Fotos climbs 2-1 on the Billboard 200 albums chart (dated Jan. 25), scoring the superstar his fourth ...

The week’s most popular albums as compiled by Luminate, based on multi-metric consumption (blending traditional album sales, track equivalent albums, and streaming equivalent albums). Lil Baby ...

Among other topics, Hudson discussed the success of Dupixent (dupilumab), highlighting that it has reached over $13bn in global sales, which affirms its commercial advantage and sets a milestone ...

The use of Sanofi’s Dupixent in atopic dermatitis has set a high benchmark for competitors within the space. Credit: marishkaSm via Shutterstock. Sanofi’s participation at the JP Morgan 43rd Annual ...

Sanofi’s chief executive Paul Hudson discussed the success of Dupixent (dupilumab)and the remarkable achievement of over $13 billion in global sales in 2024, highlighting its commercial advantage and ...

Furthermore, the successful launch of Dupixent for chronic obstructive pulmonary disease (COPD) has garnered significant coverage from top commercial and Medicare payers, indicating strong market ...